This suggests that increased access of SP1 to the PRKCB promoter in CLL cells compared to normal B cells is likely the result of histone relaxation due to permissive epigenetic marking rather than changes in gene methylation. The gene discussed is SP1; the disease is B-cell chronic lymphocytic leukemia.